Cargando…
Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk
OBJECTIVES: The SARS-CoV-2 Delta variant (B.1.617.2) is associated with increased infectivity. Data on breakthrough SARS-CoV-2 Delta variant infections in vaccinated individuals and transmission risk are limited. The aim of this study was to provide estimates of transmission risk in Delta variant br...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of The Royal Society for Public Health.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747938/ https://www.ncbi.nlm.nih.gov/pubmed/35152039 http://dx.doi.org/10.1016/j.puhe.2022.01.005 |
_version_ | 1784630952726626304 |
---|---|
author | Hsu, L. Hurraß, J. Kossow, A. Klobucnik, J. Nießen, J. Wiesmüller, G.A. Grüne, B. Joisten, C. |
author_facet | Hsu, L. Hurraß, J. Kossow, A. Klobucnik, J. Nießen, J. Wiesmüller, G.A. Grüne, B. Joisten, C. |
author_sort | Hsu, L. |
collection | PubMed |
description | OBJECTIVES: The SARS-CoV-2 Delta variant (B.1.617.2) is associated with increased infectivity. Data on breakthrough SARS-CoV-2 Delta variant infections in vaccinated individuals and transmission risk are limited. The aim of this study was to provide estimates of transmission risk in Delta variant breakthrough infections. STUDY DESIGN: A matched case-control study was performed.. METHODS: To analyse onward transmission of fully vaccinated individuals infected with B.1.617.2, we compared 85 patients (vaccination group [VG]) with an age- and sex-matched unvaccinated control group (CG; n = 85). RESULTS: Transmission of B.1.617.2 was significantly reduced (halved) in the VG. The number of infected contacts to total number of contacts per infected person was 0.26 ± 0.40 in the VG vs 0.56 ± 0.45 in the CG (P = .001). Similarly, fully vaccinated contacts were less likely to be infected by fully vaccinated infected persons (IPs) than by unvaccinated IPs (20.0% vs 37.5%), although this association was not significant. CONCLUSIONS: Fully vaccinated contacts had 50% less transmissions than unvaccinated individuals. These findings must be verified in larger sample populations, and it is especially important to investigate the role of vaccination status of close contacts. |
format | Online Article Text |
id | pubmed-8747938 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Authors. Published by Elsevier Ltd on behalf of The Royal Society for Public Health. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87479382022-01-11 Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk Hsu, L. Hurraß, J. Kossow, A. Klobucnik, J. Nießen, J. Wiesmüller, G.A. Grüne, B. Joisten, C. Public Health Short Communication OBJECTIVES: The SARS-CoV-2 Delta variant (B.1.617.2) is associated with increased infectivity. Data on breakthrough SARS-CoV-2 Delta variant infections in vaccinated individuals and transmission risk are limited. The aim of this study was to provide estimates of transmission risk in Delta variant breakthrough infections. STUDY DESIGN: A matched case-control study was performed.. METHODS: To analyse onward transmission of fully vaccinated individuals infected with B.1.617.2, we compared 85 patients (vaccination group [VG]) with an age- and sex-matched unvaccinated control group (CG; n = 85). RESULTS: Transmission of B.1.617.2 was significantly reduced (halved) in the VG. The number of infected contacts to total number of contacts per infected person was 0.26 ± 0.40 in the VG vs 0.56 ± 0.45 in the CG (P = .001). Similarly, fully vaccinated contacts were less likely to be infected by fully vaccinated infected persons (IPs) than by unvaccinated IPs (20.0% vs 37.5%), although this association was not significant. CONCLUSIONS: Fully vaccinated contacts had 50% less transmissions than unvaccinated individuals. These findings must be verified in larger sample populations, and it is especially important to investigate the role of vaccination status of close contacts. The Authors. Published by Elsevier Ltd on behalf of The Royal Society for Public Health. 2022-03 2022-01-11 /pmc/articles/PMC8747938/ /pubmed/35152039 http://dx.doi.org/10.1016/j.puhe.2022.01.005 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Short Communication Hsu, L. Hurraß, J. Kossow, A. Klobucnik, J. Nießen, J. Wiesmüller, G.A. Grüne, B. Joisten, C. Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk |
title | Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk |
title_full | Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk |
title_fullStr | Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk |
title_full_unstemmed | Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk |
title_short | Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk |
title_sort | breakthrough infections with the sars-cov-2 delta variant: vaccinations halved transmission risk |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747938/ https://www.ncbi.nlm.nih.gov/pubmed/35152039 http://dx.doi.org/10.1016/j.puhe.2022.01.005 |
work_keys_str_mv | AT hsul breakthroughinfectionswiththesarscov2deltavariantvaccinationshalvedtransmissionrisk AT hurraßj breakthroughinfectionswiththesarscov2deltavariantvaccinationshalvedtransmissionrisk AT kossowa breakthroughinfectionswiththesarscov2deltavariantvaccinationshalvedtransmissionrisk AT klobucnikj breakthroughinfectionswiththesarscov2deltavariantvaccinationshalvedtransmissionrisk AT nießenj breakthroughinfectionswiththesarscov2deltavariantvaccinationshalvedtransmissionrisk AT wiesmullerga breakthroughinfectionswiththesarscov2deltavariantvaccinationshalvedtransmissionrisk AT gruneb breakthroughinfectionswiththesarscov2deltavariantvaccinationshalvedtransmissionrisk AT joistenc breakthroughinfectionswiththesarscov2deltavariantvaccinationshalvedtransmissionrisk |